What is Birzeit Pharmaceutical Co Price-to-Operating-Cash-Flow?
As of today (2025-06-03), Birzeit Pharmaceutical Co's share price is $3.98.
Birzeit Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.19. Hence, Birzeit Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 20.84.
The historical rank and industry rank for Birzeit Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
XPAE:BPC'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.66 Med: 14.84 Max: 630
Current: 20.84
During the past 13 years, Birzeit Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 630.00. The lowest was 7.66. And the median was 14.84.
Birzeit Pharmaceutical Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2025 was $-0.01.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.19.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Birzeit Pharmaceutical Co was -10.70% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 24.20% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 1.10% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 1.70% per year.
During the past 13 years, Birzeit Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 34.90% per year. The lowest was -31.80% per year. And the median was 8.80% per year.
Birzeit Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Birzeit Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Birzeit Pharmaceutical Co Price-to-Operating-Cash-Flow Chart
|
Birzeit Pharmaceutical Co Annual Data
|
|
Trend |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
Dec24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
18.26 |
30.05 |
32.91 |
13.92 |
24.17 |
|
Birzeit Pharmaceutical Co Quarterly Data
|
|
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
Dec24 |
Mar25 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
19.72 |
22.60 |
29.17 |
24.17 |
19.32 |
Competitive Comparison of Birzeit Pharmaceutical Co's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Birzeit Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Birzeit Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Birzeit Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Birzeit Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.
Birzeit Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation
Birzeit Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 3.98 | / | 0.191 |
| = | 20.84 |
Birzeit Pharmaceutical Co's Share Price of today is $3.98.
Birzeit Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.19.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Birzeit Pharmaceutical Co Business Description
Traded in Other Exchanges
N/A
Address
Industrial Zone, P.O. Box 79, Ramallah, PSE
Birzeit Pharmaceutical Co is engaged in manufacturing pharmaceutical products. It produces Ampoules, Capsules, Tablets and Caplets, Syrups, Suspensions and Granules, Ophthalmic, Semi-solids, Powder vials, Suppositories, and Powders. It serves the Ministry of Health, local healthcare organizations, international healthcare organizations and programs, and end users through pharmacies and physicians. It carries out its activity in Palestine, Algeria, and East Europe.
Birzeit Pharmaceutical Co Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XPAE:BPC has been successfully added to your